Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2020
Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing RegimensDebika Bhattacharya, Amita Gupta, Camlin Tierney, et al.Antimicrobial Agents and Chemotherapy|January 16, 2019
Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202Cindy J Bednasz, Charles S Venuto, Qing Ma, et al.Obstetrics and Gynecology|August 3, 2023
Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled TrialDebika Bhattacharya, Camlin Tierney, Kevin Butler, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 31, 2025
Postpartum maternal monitoring for renal safety related to tenofovir exposure during breastfeeding in the PROMISE 1077BF randomized trialKristin Baltrusaitis, Camlin Tierney, Mary Glenn Fowler, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2022
Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV CoinfectionFlavia Matovu Kiweewa, Camlin Tierney, Kevin Butler, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2021
Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected InfantsCeejay L Boyce, Tatiana Sils, Daisy Ko, et al.BMC Infectious Diseases|July 20, 2022
Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trialKristin Baltrusaitis, Bonus Makanani, Camlin Tierney, et al.American Journal of Epidemiology|May 11, 2021
Transportability From Randomized Trials to Clinical Care: On Initial HIV Treatment With Efavirenz and Suicidal Thoughts or BehaviorsKatie R Mollan, Brian W Pence, Steven Xu, et al.Antimicrobial Agents and Chemotherapy|April 25, 2007
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjectsNimalie D Stone, Shelia B Dunaway, Charles Flexner, et al.Open Forum Infectious Diseases|July 25, 2024
Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine)Ceejay L Boyce, Tatiana Sils, Ross S Milne, et al.Pageof 7